These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 25525416)
1. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review. van Dijkhuizen EH; Wulffraat NM Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416 [TBL] [Abstract][Full Text] [Related]
2. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study. van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368 [TBL] [Abstract][Full Text] [Related]
3. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. Hawwa AF; AlBawab A; Rooney M; Wedderburn LR; Beresford MW; McElnay JC Arthritis Res Ther; 2015 Oct; 17():295. PubMed ID: 26493320 [TBL] [Abstract][Full Text] [Related]
5. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis. Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950 [TBL] [Abstract][Full Text] [Related]
6. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine? Roszkiewicz J; Smolewska E Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333 [TBL] [Abstract][Full Text] [Related]
7. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis. de Rotte MC; Bulatovic M; Heijstek MW; Jansen G; Heil SG; van Schaik RH; Wulffraat NM; de Jonge R J Rheumatol; 2012 Oct; 39(10):2032-40. PubMed ID: 22859359 [TBL] [Abstract][Full Text] [Related]
8. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis. Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357 [TBL] [Abstract][Full Text] [Related]
10. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602 [TBL] [Abstract][Full Text] [Related]
11. Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis. Chen Y; Zou K; Sun J; Yang Y; Liu G Pharmacogenomics; 2018 Apr; 19(6):529-538. PubMed ID: 29589488 [TBL] [Abstract][Full Text] [Related]
12. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis. Yanagimachi M; Naruto T; Hara T; Kikuchi M; Hara R; Miyamae T; Imagawa T; Mori M; Kaneko T; Morita S; Goto H; Yokota S Br J Clin Pharmacol; 2011 Feb; 71(2):237-43. PubMed ID: 21219404 [TBL] [Abstract][Full Text] [Related]
14. Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary results. Höfel L; Eppler B; Storf M; Schnöbel-Müller E; Haas JP; Hügle B Pediatr Rheumatol Online J; 2018 Feb; 16(1):11. PubMed ID: 29433504 [TBL] [Abstract][Full Text] [Related]
15. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis. Bulatovic M; Heijstek MW; Van Dijkhuizen EH; Wulffraat NM; Pluijm SM; de Jonge R Ann Rheum Dis; 2012 Sep; 71(9):1484-9. PubMed ID: 22473625 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration. Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536 [TBL] [Abstract][Full Text] [Related]
17. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis. Funk RS; Chan MA; Becker ML Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276 [TBL] [Abstract][Full Text] [Related]
18. Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis. Scheuern A; Fischer N; McDonald J; Brunner HI; Haas JP; Hügle B Pediatr Rheumatol Online J; 2016 Feb; 14(1):11. PubMed ID: 26928923 [TBL] [Abstract][Full Text] [Related]
19. Perceptions of Methotrexate Intolerance and Its Impact on Daily Life in School-Age Children with Juvenile Idiopathic Arthritis. Khan S; Mancini J; Hopper C; Rennick JE J Pediatr Nurs; 2019; 48():49-54. PubMed ID: 31254860 [TBL] [Abstract][Full Text] [Related]
20. The use of methotrexate in children with rheumatic diseases. Gutiérrez-Suárez R; Burgos-Vargas R Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]